HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections.

Abstract
The aggressive use of praziquantel to combat schistosomiasis in Egpyt raises concern about the possible emergence of resistance. Eggs from Egyptian patients with praziquantel-resistant infections (not cured by 3 doses of praziquantel) have been used to establish infection-specific schistosome isolates in mice. The response of these worms to the drug was observed in vitro, in order to determine if the isolates obtained from these resistant infections were, in fact, less responsive to praziquantel. One of the hallmark effects of praziquantel on schistosomes in vitro is a disruption of the worm's outer surface, the tegument. Here, praziquantel-induced tegumental damage is observed in 3 distinct isolates, 2 derived from resistant infections and 1 from an infection cured by a single dose. The isolates from the resistant infections were less susceptible to praziquantel-induced tegumental damage in vitro, suggesting that the worms are in some way less responsive to the drug.
AuthorsS William, S Botros, M Ismail, A Farghally, T A Day, J L Bennett
JournalParasitology (Parasitology) Vol. 122 Pt 1 Pg. 63-6 (Jan 2001) ISSN: 0031-1820 [Print] England
PMID11197765 (Publication Type: Journal Article)
Chemical References
  • Anthelmintics
  • Praziquantel
Topics
  • Animals
  • Anthelmintics (administration & dosage, therapeutic use)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Resistance
  • Egypt
  • Humans
  • Male
  • Mice
  • Microscopy, Electron, Scanning
  • Praziquantel (administration & dosage, therapeutic use)
  • Schistosoma mansoni (drug effects, ultrastructure)
  • Schistosomiasis mansoni (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: